Abstract
Introduction/BackgroundCirculating tumour DNA (ctDNA) is emerging as a potential option to detect disease recurrence in women undergoing follow-up for endometrial cancer (EC). However, ensuring patient acceptability of changing clinical practice...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have